Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	325	112	71	106	197	128
Market Cap Growth	44.91%	57.54%	-32.42%	-46.38%	53.54%	18.98%
Enterprise Value	309	96	64	90	197	117
Last Close Price	12.57	4.38	2.82	4.29	8.13	7.20
Forward PE	54.65	79.64	-	9.98	-	-
PS Ratio	9.35	3.55	3.36	4.84	5047.59	133.69
PB Ratio	20.32	7.26	5.45	5.99	12.57	12.15
P/TBV Ratio	15.31	10.47	8.57	7.54	13.05	13.05
P/FCF Ratio	154.13	16.49	14.91	-	-	-
P/OCF Ratio	153.12	16.49	14.80	-	-	-
EV/Sales Ratio	8.91	3.04	3.03	4.10	5040.62	121.60
EV/FCF Ratio	146.57	14.11	13.46	-	-	-
Debt / Equity Ratio	0.27	0.35	0.50	0.38	0.46	0.43
Debt / FCF Ratio	2.05	0.80	1.36	-	-	-
Asset Turnover	1.03	1.11	0.81	0.81	0.00	0.04
Inventory Turnover	9.44	14.42	12.53	3.16	0.54	-
Quick Ratio	1.31	1.53	2.81	4.36	5.63	6.39
Current Ratio	1.51	1.65	3.10	5.18	6.51	7.65
Return on Equity (ROE)	-33.35%	-6.56%	-58.75%	-11.74%	-213.41%	-99.42%
Return on Assets (ROA)	-9.68%	-2.62%	-19.67%	-3.47%	-78.10%	-51.22%
Return on Capital (ROIC)	-15.16%	-3.68%	-23.50%	-3.96%	-89.38%	-56.15%
Earnings Yield	-1.69%	-0.83%	-12.65%	-1.85%	-14.21%	-14.29%
FCF Yield	0.65%	6.06%	6.70%	-4.48%	-11.38%	-14.91%
Buyback Yield / Dilution	0.20%	-1.99%	0.24%	-19.98%	-18.29%	-176.74%
Total Shareholder Return	0.20%	-1.99%	0.24%	-19.98%	-18.29%	-176.74%

Source: S&P Capital IQ. Standard template. Financial Sources.